Simcere Pharmaceutical Group. Earnings: What Investors Should Watch

Simcere Pharmaceutical Group. (NYSE:SCR) will report earnings before markets open on Thursday, May 9th. Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company’s products include antibiotics, anti-cancer medications and anti-stroke medications.

Here is your Cheat Sheet to Simcere Pharmaceutical Group. Earnings:

Earnings Expectations: Analysts expect earnings of $0.08 per share on revenues of $82.83 million. Currently, the company’s P/E ratio stands at 53.79.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.11 to a profit $0.12. For the current year, the average estimate is a profit of $0.39, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Simcere Pharmaceutical Group. has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 255.55 272.41 323.80 323.43 333.82
Diluted EPS ($) 0.8219 0.0675 0.4688 0.5104 0.1699

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 81.00 77.32 83.17 83.54 86.56
Diluted EPS ($) 0.1147 0.0825 0.0786 0.0666 -0.0634

Past Performance:
Simcere Pharmaceutical Group. has beat analyst estimates 1 time in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]